NO994395L - Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat - Google Patents

Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat

Info

Publication number
NO994395L
NO994395L NO994395A NO994395A NO994395L NO 994395 L NO994395 L NO 994395L NO 994395 A NO994395 A NO 994395A NO 994395 A NO994395 A NO 994395A NO 994395 L NO994395 L NO 994395L
Authority
NO
Norway
Prior art keywords
tricalcium phosphate
stable
formulation containing
solid formulation
containing vitamin
Prior art date
Application number
NO994395A
Other languages
English (en)
Norwegian (no)
Other versions
NO994395D0 (no
Inventor
Achim Schoffler
Claudia Wildner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO994395D0 publication Critical patent/NO994395D0/no
Publication of NO994395L publication Critical patent/NO994395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO994395A 1997-03-12 1999-09-10 Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat NO994395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19710054A DE19710054A1 (de) 1997-03-12 1997-03-12 Pharmazeutische Zubereitung
PCT/EP1998/001208 WO1998040085A1 (de) 1997-03-12 1998-03-04 Stabile, feste zubereitung enthaltend vitamin d3 und tricalciumphosphat

Publications (2)

Publication Number Publication Date
NO994395D0 NO994395D0 (no) 1999-09-10
NO994395L true NO994395L (no) 1999-09-10

Family

ID=7823015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994395A NO994395L (no) 1997-03-12 1999-09-10 Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat

Country Status (20)

Country Link
EP (1) EP0969849B1 (da)
JP (1) JP2001515486A (da)
KR (1) KR20000076042A (da)
CN (1) CN1249689A (da)
AR (1) AR010903A1 (da)
AT (1) ATE245425T1 (da)
AU (1) AU730675B2 (da)
BR (1) BR9808233A (da)
CA (1) CA2284183A1 (da)
CZ (1) CZ290991B6 (da)
DE (2) DE19710054A1 (da)
DK (1) DK0969849T3 (da)
ES (1) ES2201460T3 (da)
HU (1) HUP0002928A3 (da)
NO (1) NO994395L (da)
PL (1) PL335644A1 (da)
PT (1) PT969849E (da)
SK (1) SK121699A3 (da)
WO (1) WO1998040085A1 (da)
ZA (1) ZA982073B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CA2476679A1 (en) * 2002-02-20 2003-08-28 Teijin Limited Vitamin d3 derivatives and remedies using the same
EP1342796A3 (en) * 2002-02-22 2004-01-02 Teijin Limited Compound for the treatment of paget's disease of bone
PT2266584E (pt) * 2003-05-07 2012-12-19 Osteologix As Composição com estrôncio e vitamina d para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
MX2012014872A (es) * 2010-06-24 2013-01-24 Prayon S A Compuesto activo estabilizado.
AU2014201820B2 (en) 2013-03-27 2016-05-19 Psm Healthcare Limited Stabilized vitamin D formulations
EP3042649A1 (en) * 2015-01-09 2016-07-13 S.B.M. S.r.l. A composition, comprising tricalcium phosphate and gelatin, for treating dyspepsia and related disorders
CN105982071A (zh) * 2015-02-05 2016-10-05 宁志伟 高剂量维生素d3口服制剂配方
CN104800166B (zh) * 2015-04-22 2017-11-10 青岛正大海尔制药有限公司 一种阿法骨化醇散剂及其制备方法
CN113350374B (zh) * 2021-06-23 2022-05-31 锦州医科大学 一种磷酸钙与维生素d复合微囊的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤
JP3147249B2 (ja) * 1992-03-11 2001-03-19 コベルコ建機株式会社 走行用ポンプ圧の制御装置
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
US5548203A (en) * 1994-06-29 1996-08-20 Electric Power Research Institute, Inc. Capacitor polarity-based var correction controller for resonant line conditions and large amplitude line harmonics
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement

Also Published As

Publication number Publication date
EP0969849A1 (de) 2000-01-12
EP0969849B1 (de) 2003-07-23
HUP0002928A2 (hu) 2001-02-28
DK0969849T3 (da) 2003-11-03
WO1998040085A1 (de) 1998-09-17
PL335644A1 (en) 2000-05-08
NO994395D0 (no) 1999-09-10
BR9808233A (pt) 2000-05-16
CZ322199A3 (cs) 2000-01-12
ES2201460T3 (es) 2004-03-16
CZ290991B6 (cs) 2002-11-13
CN1249689A (zh) 2000-04-05
CA2284183A1 (en) 1998-09-17
KR20000076042A (ko) 2000-12-26
AU6499798A (en) 1998-09-29
ATE245425T1 (de) 2003-08-15
SK121699A3 (en) 2000-01-18
PT969849E (pt) 2003-12-31
DE59809085D1 (de) 2003-08-28
AR010903A1 (es) 2000-07-12
HUP0002928A3 (en) 2001-04-28
ZA982073B (en) 1998-09-16
DE19710054A1 (de) 1998-09-17
JP2001515486A (ja) 2001-09-18
AU730675B2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
NO20063853L (no) Kombinasjonsterapi for osteoporose
BR9808348A (pt) Alimento medicinal para diabéticos
NO994395L (no) Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat
AR015946A1 (es) Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
WO1999032135A8 (en) Keratinocyte growth factor-2 formulations
SE9901272D0 (sv) New improved formulation
ES2190244T3 (es) Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales.
HUP0104258A2 (hu) HMG-CoA reduktáz inhibítort tartalmazó stabil gyógyszerkészítmények
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
DE60239343D1 (de) Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
CA2149052A1 (en) Dry mix formulation for bisphosphonic acids
LU91281I2 (fr) Preotact-hormone parathyroïde
BG100911A (en) Biophosphonic acids-sontaining wet-granulated form
BR9810832B1 (pt) composição farmacêutica contendo como princìpios ativos vitamina d associada a um sal de cálcio, e, processos para a preparação de uma composição farmacêutica, para o tratamento de deficiências nutricionais de cálcio e vitamina d na velhice e para reduzir a perda de tecido ósseo ligada à idade e para evitar fraturas femurais e outras fraturas não vertebrais.
WO1998058911A3 (en) Prostaglandin agonists
ITMI931649A1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
BR9608392A (pt) Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
EP0861663A3 (en) Osteoclastgenic inhibitory agent comprising interleukin-18
DK0762883T3 (da) Pyridylbisphosphonater til anvendelse som terapeutisk middel
AR019025A1 (es) Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
FR2803521B1 (fr) Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.